It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Background
Computed tomography perfusion imaging (CTPI) by repeated scanning has clinical relevance but implies relatively high radiation exposure. We present a method to measure perfusion from two CT scan phases only, considering tissue enhancement, feeding vessel (aortic) peak enhancement, and bolus shape.
Methods
CTPI scans (each with 40 frames acquired every 1.5 s) of 11 patients with advanced hepatocellular carcinoma (HCC) enrolled between 2012 and 2016 were retrospectively analysed (aged 69 ± 9 years, 8/11 males). Perfusion was defined as the maximal slope of the time-enhancement curve divided by the peak enhancement of the feeding vessel (aorta). Perfusion was computed two times, first using the maximum slope derived from all data points and then using the peak tissue enhancement and the bolus shape obtained from the aortic curve.
Results
Perfusion values from the two methods were linearly related (r2 = 0.92, p < 0.001; Bland–Altman analysis bias -0.12). The mathematical model showed that the perfusion ratio of two ROIs with the same feeding vessel (aorta) corresponds to their peak enhancement ratio (r2 = 0.55, p < 0.001; Bland–Altman analysis bias -0.68). The relationship between perfusion and tissue enhancement is predicted to be linear in the clinical range of interest, being only function of perfusion, peak feeding vessel enhancement, and bolus shape.
Conclusions
This proof-of-concept study showed that perfusion values of HCC, kidney, and pancreas could be computed using enhancement measured only with two CT scan phases, if aortic peak enhancement and bolus shape are known.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 IRCCS Policlinico San Donato, Unit of Radiology, San Donato Milanese, Italy (GRID:grid.419557.b) (ISNI:0000 0004 1766 7370)
2 Elekton S.A.S., Regione Crena 15A, Agliano Terme, Italy (GRID:grid.419557.b)
3 IRCCS Policlinico San Donato, Unit of Radiology, San Donato Milanese, Italy (GRID:grid.419557.b) (ISNI:0000 0004 1766 7370); Università degli Studi di Milano, Department of Biomedical Sciences for Health, Milan, Italy (GRID:grid.4708.b) (ISNI:0000 0004 1757 2822)
4 Università degli Studi di Milano-Bicocca, School of Medicine and Surgery, Milan, Italy (GRID:grid.7563.7) (ISNI:0000 0001 2174 1754)
5 Università degli Studi di Milano-Bicocca, School of Medicine and Surgery, Milan, Italy (GRID:grid.7563.7) (ISNI:0000 0001 2174 1754); ASST Monza—Ospedale San Gerardo, Department of Radiology, Monza, Italy (GRID:grid.415025.7) (ISNI:0000 0004 1756 8604)